{"schema_version":"secwatch.filing_event.v1","accession":"0000313143-25-000006","form_type":"8-K","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.935123+00:00","generated_at":"2026-05-28T02:26:38.262470+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Haemonetics completes sale of whole blood assets to GVS for up to $67.8M","bullets":["Total cash consideration up to $67.8M: $45.3M upfront (adjusted) plus up to $22.5M contingent.","Contingent consideration tied to three-year sales growth and other milestones.","Transaction closed on January 13, 2025, as previously disclosed in December 2024 8-K.","Assets divested are within the Blood Center business unit's whole blood segment."],"urls":{"canonical":"https://secwatch.observer/filing/0000313143-25-000006","json":"https://secwatch.observer/filing/0000313143-25-000006.json","markdown":"https://secwatch.observer/filing/0000313143-25-000006.md","text":"https://secwatch.observer/filing/0000313143-25-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000031314325000006/0000313143-25-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000031314325000006/hae-20250114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T02:26:38.262470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}